Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Sotheby's Murdoch Informs Board Of His Intention Not To Stand For Re-election

RELATED NEWS
Trade BID now with 

Sotheby's (BID: Quote) said in a filing that James Murdoch informed the Board of Directors of his intention not to stand for re-election at the May 8, 2012 Annual Meeting of Shareholders in order to focus on his core responsibilities at News Corp., where he serves as Deputy Chief Operating Officer.

James Murdoch has been a valued member of the Sotheby's Board and during his period of tenure, the company has benefitted from his broad-based marketing and brand management skills, his guidance regarding the company's strategic initiatives in Asia and his insight into digital media, among other things.

Further, Sotheby's will seek to find opportunities to continue to engage with Murdoch in the areas of his expertise.

Click here to receive FREE breaking news email alerts for Sotheby's and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
President Barack Obama is scheduled to travel to the headquarters of the Centers for Disease Control and Prevention in Atlanta, Georgia, on Tuesday to outline steps the U.S. will take to help combat the Ebola outbreak in West Africa. After recovering from an initial move to the downside, stocks have moved mostly higher over the course of the trading day on Tuesday. The major average have all turned positive, with the Nasdaq and the S&P 500 bouncing off their worst levels in almost a month. Senate Republicans once again voted Monday to block a Democratic bill aimed at narrowing the national gender wage gap. The Senate voted 52 to 40 in favor of limiting debate on the Paycheck Fairness Act, falling well short of the 60 votes required.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.